Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients With Acute Respiratory Failure Requiring High Flow Oxygen or Mechanical Ventilation: Mechanistic and Genomic Characterization Using Artificial Intelligence

NCT05363332 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT05363332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05363332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients With Acute Respiratory Failure Requiring High Flow Oxygen or Mechanical Ventilation: Mechanistic and Genomic Characterization Using Artificial Intelligence
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
November 15, 2021
Completion date
November 15, 2024
Enrollment
126 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, critical illness, hypoxemic respiratory failure, mechanical ventilation complication, neurocognitive dysfunction